Sunnyvale, CA – April 13, 2022 – JSR Life Sciences, LLC is pleased to announce that JSR Corporation (JSR) and Asahi Kasei Medical Co., Ltd. (Asahi Kasei Medical) have entered into a co-promotion agreement for bioprocess products that initiated sales collaborations in Europe and North America on April 1, 2022.
JSR and Asahi Kasei Medical both supply key manufacturing technologies to the biopharmaceutical industry, with JSR providing chromatography resin and Asahi Kasei Medical providing filters for virus filtration and cell harvesting/clarifications. Through this collaboration, the companies will each broaden their access to sales channels and strengthen the sales potential of their respective products.
“This is an exciting collaboration because both companies can now offer more value to customers through JSR and Asahi Kasei Medical’s complementary products,” said Hideaki Nomura, general manager of the Bioprocess Department at the Life Sciences Division of JSR. “It’s a good fit because JSR takes great pride in our high-quality standards and the level of support we provide to customers.”
“This collaboration will leverage leading-edge technologies and expertise that both companies already have underway,” said Ken Shinomiya, director and head of the Bioprocess Division of Asahi Kasei Medical. “This agility to customer-centric innovation is one of many actions that we do with an aim to provide "Assurance Beyond Expectation" to our customers.”
Through these activities, both companies will help customers accelerate the development and time-to-market of biopharmaceutical therapeutics.
Asahi Kasei Medical Co., Ltd. contributes to the advancement of medical treatment worldwide via continuous innovation in various fields, including medical device systems that respond to unmet needs, filters that improve the quality of blood transfusion products, and products that enable safe and efficient production of biotherapeutics and other medicines at the cutting edge of new drug development. Asahi Kasei Bioprocess, a division of Asahi Kasei Medical, supplies innovative bioprocessing tools and services that enhance the safety, manufacturing efficiency, and purity of modern biotherapeutics and pharmaceuticals. With offerings in purification, fluid management solutions, and pathogen safety testing services, Asahi Kasei Bioprocess provides a growing set of technologies that enable manufacturers of regulated therapeutics to safely and efficiently produce medicines that patients can trust. For more information, visit www.ak-bio.com.
JSR Life Sciences, LLC is changing human health as a strategic partner and pathfinder for the life sciences industry. Rooted in a history of materials innovation, JSR Life Sciences provides specialized products, materials, and services to biopharmaceutical companies and academic researchers. Together with its world-class affiliates, JSR Life Sciences offers best-in-class integrated services that de-risk molecule selection, accelerate biologic development timelines, increase clinical success rates, and develop novel in vitro diagnostics. JSR Life Sciences’ global network of affiliates includes Crown Bioscience, KBI Biopharma, Inc., Selexis SA, and MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. The company operates R&D and applications labs, manufacturing facilities, and sales offices worldwide. For more information, visit JSRLifeSciences.com
Contact details
-
- Missy Bindseil
-
JSR Life Sciences Company Inquiries
Director, Marketing & Communications - mbindseil@jsr-nahq.com
Copy link
https://news.jsrlifesciences.com/211678-jsr-and-asahi-kasei-medical-enter-co-promotion-agreementRelated topics
Related news
JSR Life Sciences to Launch Amsphere™ A+, a Next-Generation Protein A Resin for Antibody Drug Purification
Amsphere™ A+ enhances antibody drug production with advanced polymer technology and high binding capacity, debuting at BPI 2024 and BioJapan.
JSR Active Innovation Fund LLC invests in Aillis, Inc., which develops and sells AI medical devices
JSR-AIF participated in the Series D financing of Aillis for the purpose of raising funds to accelerate research and development of AI medical devices, sales, and marketing promotion
JSR Begins Development of Raw Materials from Biomass
Through joint development with Bacchus Bio innovation, JSR will develop and produce raw materials for its key biomass products utilizing synthetic biology.
Ajinomoto Co., Inc. and JSR Corporation Agree to Collaborate in Development of Global Biopharmaceutical Culture Media...
Ajinomoto Co. has reached an agreement with JSR to collaborate on the global expansion of its biopharmaceutical culture media business, adding new high-performance media developed by JSR, to Ajinom...
JSR Invites AuB Co., Ltd. to Kawasaki Collaborative Research Facility, JSR BiRD, Challenging Value Creation in the Mi...
JSR Corporation announced today that it has entered into a facility usage agreement with AuB, a company engaged in the study of intestinal microbiota in athletes.